Volume : 09, Issue : 07, July – 2022



Authors :

Koteeswaran. K*

Abstract :

COVID-19 that is Corona Virus disease 2019 has been considered as major life- threatening disease, and it is danger to the human population worldwide then, they are caused by Severe Acute Respiratory Syndrome Corona Virus-2 that is SARS-CoV-2. The traditional Indian medicines also play an important role for targeting of SARAS-CoV-2 and its pathway. Amid of Siddha Medicines, the formulation of Kabasura Kudieer and they are composed of 15 ingredients which are used for against fever caused by respiratory infection. That traditional formulation of Kabasura Kudineer Chooranam used by Siddha practitioners because they are effectively and managing the common respiratory ailments such as flu and cold, and also they possess strong antioxidant, anti-viral, anti-bacterial, anti-fungal, anti-inflammatory, analgesic, anti pyretic and immunomodulatory properties. But these 15 ingredients have some unique characteristic features of its own then, they are extensively used for the lung boosting, and also respiratory mechanism improving, and treating for cold, cough, fever and other respiratory infection. Normally the powdered form of churnam is consumed after they are infusing it in water and making a decoction like consistency. In my review article explained that by modification of Kabasura Kudieer in Sublingual formulation, they are placed under the tongue and they are directly absorbed from the tiny blood vessels via capillaries and they enter much more quickly than oral medication, without experiencing liver metabolism they dispense full amount of mediation directly into blood stream. As a result before absorption they are not interacts with other food and medication and also they do not cause the gastrointestinal irritation of some oral medication.
Keywords: Kabasura Kudineer Choornam, Antioxidant, Respiratory disease, Sublingual tablet, evaluation

Cite This Article:

Please cite this article in press K. Koteeswaran et al, A Hypothetical Review Of Making Sublingual Formulation By Using Kabasura Kudineer Chooranam For Prevention And Management Of Covid-19 Virus., Indo Am. J. P. Sci, 2022; 09(7).,

Number of Downloads : 10


1. Mahadevan H, Palraj V. Literature review on Siddha herbal formulations (Kudineer) available for the management of Dengue. International Journal of Pharmacology and Clinical Sciences. 2016;5(3).
2. http://www.thesiddha.com/siddha-medicine.
3. http://healthmantra.com/siddha/origin.shtml.
4. http://nischennai.org/siddhamedicine.html.
5. John A, Jayachandran R, Ethirajulu S, Sathiyarajeswaran P. Analysis of Kaba Sura Kudineer Chooranam-a siddha formulation. Int Ayurvedic Med J. 2015 Sep;3(9):2915-20.
6. Mahadevan H, Palraj V. Literature review on Siddha herbal formulations (Kudineer) available for the management of Dengue. International Journal of Pharmacology and Clinical Sciences. 2016;5(3).
7. Thanigavelan V, Kaliyamurthi V, Kumar MP, Elansekaran S, Rajamanickam GV. An overview of the Herbs in a Siddha Polyherbal decoction-Pidangunaari Kudineer indicated for Hepatomegaly. Journal of Applied Pharmaceutical Science. 2012 Jul 30;2(7):08-14.
8. Rajeshkumar S, Kumar SV, Ramaiah A, Agarwal H, Lakshmi T, Roopan SM. Biosynthesis of zinc oxide nanoparticles usingMangifera indica leaves and evaluation of their antioxidant and cytotoxic properties in lung cancer (A549) cells. Enzyme and microbial technology. 2018 Oct 1;117:91-5.
9. Sujitha, J., Asokan, S. and Rajeshkumar, S. Antidermatophytic Activity of Green synthesized Zinc oxide nanoparticles using Cassia Alata Leaves. Journa of Microbilogy, Biotechnology and Food science, 2018, pp. PP. 348-352. doi: 10.15414/jmbfs.2018.7.4.348-352.
10. Zysk KG. Religious Medicine: History and Evolution of Indian Medicine. Routledge; 2017 Oct 23.
11. Lakshmi T, Krishnan V, Rajendran R, Madhusudhanan N. Azadirachta indica: A herbal panacea in dentistry–An update. Pharmacognosy reviews. 2015 Jan;9(17):41.
12. Lakshmi T, Ezhilarasan D, Vijayaragavan R, Bhullar SK, Rajendran R. Acacia catechu ethanolic bark extract induces apoptosis in human oral squamous carcinoma cells. Journal of advanced pharmaceutical technology & research. 2017 Oct;8(4):143.
13. Anbarasu K, Manisenthil KK, Ramachandran S. Antipyretic, anti-inflammatory and analgesic properties of nilavembu kudineer choornam: a classical preparation used in the treatment of chikungunya fever. Asian Pacific journal of tropical medicine. 2011 Oct 1;4(10):819-23.
14. Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID‐19: a systematic review and meta‐analysis. Clinical otolaryngology. 2020 Nov;45(6):914-22.
15. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020 Apr 14;323(14):1406-7.
16. Ishikawa T, Koizumi N, Mukai B, UTOGUCHI N, FUJII M, MATSUMOTO M, ENDO H, SHIROTAKE S, WATANABE Y. Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules. Chemical and pharmaceutical bulletin. 2001;49(2):230-2.
17. KL moore, AF Dalley, Anne MR. Agur. Eds. Clinically Oriented Anatomy. 6th edition. [book auth.] Lippincott Williams and Wilkins. Philadelphia : s.n., 2009, p. p.944.
18. Kurosaki Y, Takatori T, Nishimura H, Nakayama T, Kimura T. Regional variation in oral mucosal drug absorption: permeability and degree of keratinization in hamster oral cavity. Pharmaceutical research. 1991 Oct;8(10):1297-301.
19. Richman MD, Fox CD, Shangraw RF. Preparation and stability of glyceryl trinitrate sublingual tablets prepared by direct compression. Journal of pharmaceutical sciences. 1965 Mar 1;54(3):447-51.
20. Koland M, Sandeep VP, Charyulu NR. Fast dissolving sublingual films of ondansetron hydrochloride: effect of additives on in vitro drug release and mucosal permeation. Journal of Young Pharmacists. 2010 Jul 1;2(3):216-22.
21. Bayrak Z, Tas C, Tasdemir U, Erol H, Ozkan CK, Savaser A, Ozkan Y. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: In vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 2011 Aug 1;78(3):499-505.
22. Chang RK, Guo X, Burnside BA, Couch RA. Fast-dissolving tablets. Pharmaceutical technology. 2000;24(6):52-.
23. https://pharmlabs.unc.edu./labs/tablets/molded.htm
24. Okuda Y, Okamoto Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. Formulation design for orally disintegrating tablets containing enteric-coated particles. Chemical and Pharmaceutical Bulletin. 2014 May 1;62(5):407-14.
25. Anil PA, Solanki KP, Pandya V, Dholakia S. Fast Dissolving Tablets: As a Preferred Alternative to conventional tablets.
26. van Schaick EA, Lechat P, Remmerie BM, Ko G, Lasseter KC, Mannaert E. Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers. Clinical therapeutics. 2003 Jun 1;25(6):1687-99.
27. Sheeba FR, Acharya GD, Rameshwari S, Jeya AJ. Formulation and evaluation of nifedipine sublingual tablets. Asian J Pharm Clin Res. 2009 Jul;2(3):44-8.
28. Haegeli L, Brunner‐La Rocca HP, Wenk M, Pfisterer M, Drewe J, Krähenbühl S. Sublingual administration of furosemide: new application of an old drug. British journal of clinical pharmacology. 2007 Dec;64(6):804-9.
29. MD, ed. Rockville. USP/NF. Physical Tests: disitegration 22/17. United States Pharmacopoeial Convettion Inc. 1990,